HOME >> MEDICINE >> NEWS
Medical experts unite to raise awareness of risk, threat of blood clots

Council for Leadership on Thrombosis Awareness and Management formed to advance prevention and treatment of overlooked public health problem

TARRYTOWN, NY, February 14, 2002 -- Calling deep-vein thrombosis (DVT), or blood clots, an underestimated public health problem, the Council for Leadership On Thrombosis (CLOT) Awareness and Management announced its formation today to raise awareness, advance prevention and treatment, and reduce the dangers of DVT, a potentially life-threatening condition that affects approximately 2 million Americans per year.

Comprised of medical experts representing various specialties and affiliated with leading U.S. institutions, the Council plans to target both health care professionals and the general public with such major initiatives as a national DVT FREE screening program of 7,500 patients at more than 200 hospitals, and the ClotAlert Resource Center, a multifaceted campaign to educate consumers, physicians and health professionals about the risk factors and symptoms of DVT.

Deep-vein thrombosis represents one of the most commonly occurring and serious medical conditions, yet it has never received the same attention as heart attack or stroke, said Samuel Z. Goldhaber, MD, director of Venous Thromboembolism Research Group and Cardiac Centers Anticoagulation Service at Brigham and Womens Hospital in Boston, Mass., associate professor of medicine, Harvard Medical School, and co-chair of the Council for Leadership On Thrombosis Awareness and Management. The public is not nearly as educated about the potential health risk of DVT, nor is the public aware of the symptoms associated with blood clots. Our mission as a Council is to raise awareness of DVT so the public can recognize the symptoms and urgently seek medical help.

This is the first time that DVT has been portrayed as a true public health problem, said Victor Tapson, MD, associate professor, Division of Pulmonary Medicine, Department of
'"/>

Contact: Kristen Supchak
kristens@mcspr.com
908-234-9900
MCS
14-Feb-2002


Page: 1 2 3

Related medicine news :

1. Medically supervised drug injection facilities safer for users
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
4. UCLA Medical Center becomes first hospital to introduce remote presence robots in ICU
5. New data on Orqis Medicals Cancion CRS to be reported at ACC
6. Medical technologies may hinder rather than help newborn survival
7. Medical meeting to feature research findings and disease prevention and health promotion sessions
8. LA BioMed Medical/Research briefs January 2005
9. Medical negligence system is secretive, unaccountable and unregulated
10. Dartmouth Medical School receives $1.6 million in AIDS funding
11. LA BioMed Medical/Research Briefs December 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Medical experts unite raise awareness risk threat blood clots

(Date:3/5/2015)... New York, New York (PRWEB) March 05, 2015 ... behalf of men who allegedly suffered heart attacks, strokes ... of prescription low testosterone therapies continue to move forward ... District Court, Northern District of Illinois. According to a ... has set forth procedures for the use of master ...
(Date:3/5/2015)... 2015 The Maricopa Community Colleges ... to the Arizona economy each year, according to a ... Economic Value of Maricopa County Community College District, summarizes ... district in fiscal year 2013-2014. , The analysis ... (EMSI), an organization that specializes in providing economic impact ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading provider ... management arena, is pleased to announce a webinar focusing ... Careā„¢ (ACUITY) version 7.20. The session will focus on ... of automation. , The webinar, scheduled for March 18, ... Jeff Frater, RN, BSN, Director of Partner Development at ...
(Date:3/5/2015)... Califia Farms , the fastest-growing ... products coffee drinks category[1], today unveils its new Concentrated ... Anaheim, Calif. Concentrated Cold Brew (CCB) is the ... democratizes the next wave of the coffee-taste evolution by ... become their own baristas. , Califia Farms CCB ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 For PASCHA ... and most essential ingredients, the robust flavor of the ... reactions. PASCHA Chocolate is free from peanuts, nuts, ... Experience PASCHA's offering March 6th- 8th at Expo West., ... PASCHA Chocolate has broken new ground with their ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2
(Date:3/5/2015)... 5, 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), ... treatment of chronic pain, today announced the appointment ... roles. The panel of experts will provide support ... to advance the company pipeline of novel investigational ... in a range of areas including opioid receptors, ...
(Date:3/5/2015)... 2015 LUNGevity Foundation, the nation,s leading ... Administration,s (FDA) approval of Bristol Myers Squibb,s new ... treatments add another critical new treatment option to ... a patient,s own immune system to fight cancerous ... for patients with squamous cell lung cancer, a ...
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ) ... Outlook 2015: Year to Watch out for Authorized Generics ... their offering. The new pricing system ... -2014 (Annexure 1) is a game changer initiative. It ... innovator. The most of the companies are revalidating their ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
Cached News: